A new series of substituted benzylamino- and heterocyclylmethylamino carbodithioate derivatives of 4-(3H)-quinazolinone were synthesized via four steps starting from 2-amino-5-methylbenzoic acid and initially screened against A-549 (human non-small cell lung cancer), HCT-8 (human colon cancer), and Bel-7402 (human liver cancer) cell lines at the single concentration of 5 mu g/mL using the colorimetric MTT assay. The IC50 values were determined for the compounds reaching >= 70% inhibition in primary screening by serial dilution. Among the newly synthesized compounds, 9n exhibited potent in vitro cytotoxicity against A-549, HCT-8, and Bel-7402 cell lines with the IC50 values of 1.65, 0.93, and 1.43 mu M, respectively.
机构:
Choongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South KoreaChoongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South Korea
Baek, DJ
;
Park, YK
论文数: 0引用数: 0
h-index: 0
机构:
Choongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South KoreaChoongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South Korea
Park, YK
;
Heo, HI
论文数: 0引用数: 0
h-index: 0
机构:
Choongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South KoreaChoongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South Korea
Heo, HI
;
Lee, MH
论文数: 0引用数: 0
h-index: 0
机构:
Choongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South KoreaChoongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South Korea
Lee, MH
;
Yang, ZY
论文数: 0引用数: 0
h-index: 0
机构:
Choongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South KoreaChoongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South Korea
Yang, ZY
;
Choi, MH
论文数: 0引用数: 0
h-index: 0
机构:
Choongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South KoreaChoongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South Korea
机构:
Newcastle Univ, Med Sch, Canc Res Unit, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, EnglandNewcastle Univ, Med Sch, Canc Res Unit, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
Curtin, N. J.
;
Hughes, A. N.
论文数: 0引用数: 0
h-index: 0
机构:
Newcastle Gen Hosp, Northern Ctr Canc Treatment, Newcastle Upon Tyne, Tyne & Wear, EnglandNewcastle Univ, Med Sch, Canc Res Unit, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
机构:
Choongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South KoreaChoongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South Korea
Baek, DJ
;
Park, YK
论文数: 0引用数: 0
h-index: 0
机构:
Choongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South KoreaChoongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South Korea
Park, YK
;
Heo, HI
论文数: 0引用数: 0
h-index: 0
机构:
Choongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South KoreaChoongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South Korea
Heo, HI
;
Lee, MH
论文数: 0引用数: 0
h-index: 0
机构:
Choongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South KoreaChoongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South Korea
Lee, MH
;
Yang, ZY
论文数: 0引用数: 0
h-index: 0
机构:
Choongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South KoreaChoongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South Korea
Yang, ZY
;
Choi, MH
论文数: 0引用数: 0
h-index: 0
机构:
Choongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South KoreaChoongwae Pharma Co, R&D Div, Res Lab, Drug Discovery Lab 1, Suwon, South Korea
机构:
Newcastle Univ, Med Sch, Canc Res Unit, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, EnglandNewcastle Univ, Med Sch, Canc Res Unit, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
Curtin, N. J.
;
Hughes, A. N.
论文数: 0引用数: 0
h-index: 0
机构:
Newcastle Gen Hosp, Northern Ctr Canc Treatment, Newcastle Upon Tyne, Tyne & Wear, EnglandNewcastle Univ, Med Sch, Canc Res Unit, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England